143 related articles for article (PubMed ID: 32348690)
21. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA LINP1 promoted proliferation and invasion of ovarian cancer via inhibiting KLF6.
Li Y; Hou CZ; Dong YL; Zhu L; Xu H
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):36-42. PubMed ID: 31957816
[TBL] [Abstract][Full Text] [Related]
23. Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
Taniguchi H; Jacinto FV; Villanueva A; Fernandez AF; Yamamoto H; Carmona FJ; Puertas S; Marquez VE; Shinomura Y; Imai K; Esteller M
Oncogene; 2012 Apr; 31(15):1988-94. PubMed ID: 21892211
[TBL] [Abstract][Full Text] [Related]
24. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
[TBL] [Abstract][Full Text] [Related]
26. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
27. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
28. DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2.
Lian Y; Yang J; Lian Y; Xiao C; Hu X; Xu H
Cancer Commun (Lond); 2018 Oct; 38(1):64. PubMed ID: 30367681
[TBL] [Abstract][Full Text] [Related]
29. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
30. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of LncRNA GHET1 suppresses prostate cancer cell proliferation by inhibiting HIF-1α/Notch-1 signaling pathway via KLF2.
Zhu Y; Tong Y; Wu J; Liu Y; Zhao M
Biofactors; 2019 May; 45(3):364-373. PubMed ID: 30609158
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Li Y; Zhuang W; Huang M; Li X
Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
[TBL] [Abstract][Full Text] [Related]
33. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8():50. PubMed ID: 25966845
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
Zhang S; Zhang G; Liu J
APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
[TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.
Fei F; He Y; He S; He Z; Wang Y; Wu G; Li M
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30042166
[TBL] [Abstract][Full Text] [Related]
38. Silencing of O-linked N-acetylglucosamine transferase ameliorates hypercalcemia-induced neurotoxicity in renal failure by regulating EZH2/KLF2/CXCL1 axis.
Cao Y; Chen X; Sun H
Cell Death Dis; 2021 Aug; 12(9):819. PubMed ID: 34462420
[TBL] [Abstract][Full Text] [Related]
39. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]